Dicerna Pharma (DRNA) Tops Q1 EPS by 8c

Dicerna Pharma (NASDAQ: DRNA) reported Q1 EPS of ($0.30), $0.08 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.87 million.

For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery